Login to Your Account

Serono Drops Two Phase III Programs; CancerVax Falls

By Karen Pihl-Carey

Thursday, April 7, 2005
Serono SA had a double dose of news Wednesday, stopping two of its Phase III programs: onercept for psoriasis, and newly partnered product Canvaxin for Stage IV melanoma. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription